Moreover, subsequent studies confirmed that interference with SMC4 mRNA expression effectively inhibited the proliferation, migration, and invasive ability of breast cancer MDA-MB-231 cells, with the mechanism possibly related to the activation of the PI3K/AKT signaling pathway (26–28). The gene discussed is SMC4; the disease is breast cancer.